BRIEF: Pfizer says could apply for U.S. emergency use approval for vaccine in late November


(Reuters) – Pfizer Inc said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany’s BioNTech SE as soon as a safety milestone is achieved in the third week of November.